BlackRock, Inc. 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | BlackRock Inc. BLK | 3,866,202 5.500% | 1,109,527 (+40.25%) | Filing |
| 2022-01-10 12:54 pm Sale | 2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | BlackRock Inc. BLK | 2,756,675 4.990% | -1,523,737 (-35.60%) | Filing |
| 2021-01-29 5:23 pm Purchase | 2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | BlackRock Inc. BLK | 4,280,412 8.500% | 1,523,713 (+55.27%) | Filing |